Heidelberg Innovation

What Heidelberg Innovation does

Heidelberg Innovation is a privately held German investment company headquartered in Heidelberg that focuses on the life sciences sector, with a particular emphasis on medical technology. Founded in 1997, the firm operates with a small team of 1-10 employees and is structured as a boutique investment entity rather than a product or technology company.

The firm's functional role is to deploy capital into life sciences and medical technology opportunities, likely leveraging Heidelberg's positioning within one of Germany's prominent research and life sciences clusters. The input data provides no details on portfolio holdings, fund vehicles, AUM, ticket sizes, investment stages (seed through growth), co-investor relationships, or realized exits, so the scope and strategy of its investment activity cannot be characterized beyond the stated sector focus.

The business model of a firm of this profile typically derives revenue from management fees, carried interest on successful exits, and/or direct equity returns on portfolio holdings. No pricing, revenue, or fee structure information is disclosed in the supplied data. Notably, the firm's web presence (hd-innovation.de) is currently an IONOS domain parking page rather than an active corporate site, indicating limited public-facing communications or a lapse in web maintenance.

Name

Heidelberg Innovation

Website

https://hd-innovation.de

Company type

Private

Founded year

1997

Headcount range

1–10 employees

Short description

Heidelberg Innovation is a privately held, small German investment firm based in Heidelberg, founded in 1997, that invests in life sciences companies with a focus on medical technology.

Ownership category

akta.pro rank

Headquarters

HQ city

Heidelberg

HQ country

Germany

HQ region

Europe

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel

Core offering

Heidelberg Innovation is a German investment company that channels capital into life sciences companies, with a particular focus on medical technology. It operates as a privately held, small-scale investor headquartered in Heidelberg, Germany, founded in 1997. No specific investment vehicles, funds, or program offerings are detailed in the available source material.

Differentiator

Problem solved

Functional benefit

Ideal customer profiles1 record

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Direct peers

• Seventure Partners: Paris-based venture capital firm with a dedicated Life Sciences fund investing across Europe in biotech, medtech, and digital health. Comparable as a specialist European life sciences investor.
• MIG Capital: Munich-based venture capital firm investing in German-speaking deep-tech, life sciences, and medtech companies. Comparable as a DACH-region specialist investor in life sciences ventures.
• BioMedPartners: Switzerland-based life sciences venture capital firm focused on early- to growth-stage biotech, medtech, and diagnostics in the DACH region. Comparable by geography, sector focus, and fund size.
• Wellington Partners: European venture capital firm with a long-standing life sciences practice investing in therapeutics, medtech, and diagnostics. Directly comparable as a specialized European life sciences/medtech investor.
• Earlybird Health: Germany-based venture capital firm with a dedicated health and life sciences practice investing in European biotech and medtech. Comparable to Heidelberg Innovation as a specialist European life sciences investor of similar boutique scale.
• Coparion: Cologne-based venture capital firm providing growth capital to German Mittelstand-adjacent and technology-driven businesses, with life sciences exposure. Comparable as a mid-sized German venture investor.
• HTGF (High-Tech Gründerfonds): Germany's leading early-stage technology investor, with active participation in life sciences and medtech financings. Comparable as a German-domiciled specialist investor in technology and life sciences.

Broad incumbents

• M Ventures: Corporate venture arm of Merck KGaA investing in life sciences, performance materials, and emerging technology. Comparable as a sophisticated life sciences investor in the DACH ecosystem, though typically larger cheque sizes and a corporate parent.

Regional players

• Bayern Kapital: Bavaria-based venture capital firm investing in innovative technology, life sciences, and industrial companies. Comparable as a German regional life sciences investor, though focused on Bavaria rather than the Heidelberg/Baden-Württemberg region.
• NRW.BANK.Venture: Public German venture capital vehicle operated by NRW.BANK, investing in early- and growth-stage technology and life sciences companies. Comparable in mandate (DACH life sciences investment) but operates from a different German region and is government-backed.

Market position

Strengths3 records

Weaknesses3 records

Competitive moat2 records

Key risks4 records

Key highlights3 records

Customer concentration

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments10 records

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Heidelberg Innovation